PDT Partners LLC Takes Position in Alignment Healthcare, Inc. $ALHC

PDT Partners LLC purchased a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 90,507 shares of the company’s stock, valued at approximately $2,155,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ALHC. Summit Securities Group LLC acquired a new position in Alignment Healthcare during the 4th quarter valued at about $26,000. Versant Capital Management Inc boosted its stake in shares of Alignment Healthcare by 463.3% in the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after purchasing an additional 1,135 shares during the last quarter. Parallel Advisors LLC grew its position in shares of Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after buying an additional 773 shares during the period. Larson Financial Group LLC acquired a new stake in shares of Alignment Healthcare during the 3rd quarter worth approximately $33,000. Finally, Signature Equity Partners LLC bought a new stake in shares of Alignment Healthcare during the first quarter worth approximately $46,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Price Performance

NASDAQ ALHC opened at $13.90 on Thursday. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.70 and a current ratio of 1.70. The stock has a market cap of $2.88 billion, a price-to-earnings ratio of 73.16 and a beta of 1.10. The business has a 50 day simple moving average of $18.42 and a 200 day simple moving average of $18.63. Alignment Healthcare, Inc. has a 52-week low of $12.70 and a 52-week high of $25.12.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. The firm had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The business’s revenue was up 31.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.07 earnings per share. Analysts anticipate that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ALHC. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. UBS Group reissued a “neutral” rating on shares of Alignment Healthcare in a research note on Wednesday, July 8th. Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. Seven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $23.60.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Hyong Kim sold 35,951 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total value of $713,986.86. Following the sale, the insider directly owned 331,750 shares of the company’s stock, valued at approximately $6,588,555. The trade was a 9.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John E. Kao sold 298,000 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $13.88, for a total transaction of $4,136,240.00. Following the completion of the transaction, the chief executive officer directly owned 790,766 shares of the company’s stock, valued at approximately $10,975,832.08. The trade was a 27.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,009,951 shares of company stock valued at $18,597,287 over the last quarter. 5.20% of the stock is currently owned by corporate insiders.

More Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Neutral Sentiment: An AAII report discussed why Alignment Healthcare stock had risen, but the available headline provides no specific new fundamental catalyst, such as improved earnings guidance or a business announcement. Why Alignment Healthcare Stock Is Up
• Neutral Sentiment: Reported August short-interest data showed zero shares and a zero-day days-to-cover ratio, an internally inconsistent result that is unlikely to provide a meaningful signal for ALHC investors. Alignment Healthcare Short Interest Report
• Negative Sentiment: Kaplan Fox announced multiple investigations into Alignment Healthcare, its officers and directors, and potential violations of federal securities laws. The firm is seeking investors who suffered losses or have relevant information, raising the possibility of future shareholder claims. These are investigations and do not establish wrongdoing. Kaplan Fox Investigation
• Negative Sentiment: Lowey Dannenberg separately said it is investigating potential federal securities-law violations involving ALHC. The second law-firm inquiry reinforces near-term litigation uncertainty and could weigh on investor sentiment. Lowey Dannenberg Investigation
• Negative Sentiment: Kaplan Fox also urged Alignment Healthcare investors to contact the firm regarding a possible securities claim, repeating the investigation-related overhang across several releases. Kaplan Fox Possible Securities Claim

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.